Amending the marketing authorisation granted by Decision C(2022) 7342(final) for “Comirnaty - tozinameran, COVID-19
2022/2991(RSP)
Draft granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council
2022/2940(RSP)
The market of products containing, consisting of or produced from genetically modified maize MON 87419 pursuant to
2023/2759(RSP)